118 related articles for article (PubMed ID: 8136267)
1. Establishment of a leukaemic cell line from a patient with acquisition of chromosomal abnormalities during disease progression in myelodysplastic syndrome.
Nakagawa T; Matozaki S; Murayama T; Nishimura R; Tsutsumi M; Kawaguchi R; Yokoyama Y; Hikiji K; Isobe T; Chihara K
Br J Haematol; 1993 Nov; 85(3):469-76. PubMed ID: 8136267
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a novel human monocytic leukemia cell line (KP-1) expressing scavenger receptor.
Adachi N; Takaki K; Nakamura R; Ohta T; Naito M; Horiuchi S; Matsuda I
Pediatr Res; 1993 Sep; 34(3):258-64. PubMed ID: 8134164
[TBL] [Abstract][Full Text] [Related]
3. The SKM-1 leukemic cell line established from a patient with progression to myelomonocytic leukemia in myelodysplastic syndrome (MDS)-contribution to better understanding of MDS.
Nakagawa T; Matozaki S
Leuk Lymphoma; 1995 Apr; 17(3-4):335-9. PubMed ID: 8580805
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome.
Hamaguchi H; Suzukawa K; Nagata K; Yamamoto K; Yagasaki F; Morishita K
Br J Haematol; 1997 Aug; 98(2):399-407. PubMed ID: 9266939
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a human myeloid cell line from Philadelphia chromosome-negative myeloblastic leukemia arising in a patient with myelodysplastic syndrome.
McCarty TM; Rajaraman S; Elder FF; Gadson P; Thompson EB
Blood; 1987 Nov; 70(5):1665-72. PubMed ID: 3478106
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.
Sugimoto K; Hirano N; Toyoshima H; Chiba S; Mano H; Takaku F; Yazaki Y; Hirai H
Blood; 1993 Jun; 81(11):3022-6. PubMed ID: 8499637
[TBL] [Abstract][Full Text] [Related]
7. Alterations of p53 and Rb genes in a novel human GM-CSF-dependent myeloid cell line (OHN-GM) established from therapy-related leukaemia.
Nagai M; Fujita M; Ikeda T; Ohmori M; Kuwabara H; Yamaoka G; Tanaka K; Kamada N; Taniwaki M; Inoue T; Irino S; Takahara J
Br J Haematol; 1997 Aug; 98(2):392-8. PubMed ID: 9266938
[TBL] [Abstract][Full Text] [Related]
8. Unbalanced translocation der(11)t(11;12)(q23;q13): a new recurrent cytogenetic aberration in myelodysplastic syndrome with a complex karyotype.
Yamamoto K; Hato A; Minagawa K; Yakushijin K; Urahama N; Gomyo H; Sada A; Okamura A; Ito M; Matsui T
Cancer Genet Cytogenet; 2004 Nov; 155(1):67-73. PubMed ID: 15527905
[TBL] [Abstract][Full Text] [Related]
9. Necessary stem cell transplantation using myeloablative therapy for myelodysplastic syndrome with progression of genotypic abnormalities and TP53 dysfunction in a young adult.
Sato Y; Kurosawa H; Fukushima K; Okuya M; Yabe H; Arisaka O
Pediatr Transplant; 2014 Nov; 18(7):E255-7. PubMed ID: 25130056
[TBL] [Abstract][Full Text] [Related]
10. A novel unbalanced whole-arm translocation der(3;10)(q10;q10) in acute monocytic leukemia.
Yamamoto K; Okamura A; Wakahashi K; Katayama Y; Shimoyama M; Matsui T
Cancer Genet Cytogenet; 2010 Jun; 199(2):134-8. PubMed ID: 20471517
[TBL] [Abstract][Full Text] [Related]
11. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
Niimi H; Harada H; Harada Y; Ding Y; Imagawa J; Inaba T; Kyo T; Kimura A
Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
[TBL] [Abstract][Full Text] [Related]
12. [Establishment and characterization of a human acute monocytic leukemic cell line, SHI-1, carrying t(6;11)(q27;23) and p53 gene alteration].
Chen SN; Xue YQ; Zhang XG; Wu YF; Pan JL; Wang Y; Cen JN
Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):94-9. PubMed ID: 15921626
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a novel acute monoblastic leukemia cell line (YK-M2) having a near-triploid karyotype.
Ohno H; Fukuhara S; Doi S; Yamasowa M; Arita Y; Sasada M; Ohno Y; Akasaka K; Uchino H
Cancer Res; 1986 Dec; 46(12 Pt 1):6400-5. PubMed ID: 3465438
[TBL] [Abstract][Full Text] [Related]
14. [An adolescent case of myelodysplastic syndrome following aplastic anemia].
Yoshihara T; Morimoto A; Itoi T; Nakagawa M; Kawakatsu H; Todo S; Morioka Y; Imashuku S; Hayano T; Okamoto T
Rinsho Ketsueki; 1989 Jan; 30(1):78-83. PubMed ID: 2716203
[TBL] [Abstract][Full Text] [Related]
15. P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.
Yeargin J; Cheng J; Yu AL; Gjerset R; Bogart M; Haas M
J Clin Invest; 1993 May; 91(5):2111-7. PubMed ID: 8486778
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndrome.
Bogdanović G; Jurisić V; Kraguljac N; Mrdjanović J; Jakimov D; Krtolica K; Krajnović M; Magić Z; Stojiljković B; Andrijević L; Srdić T; Baltić M; Popović S
Leuk Res; 2007 Aug; 31(8):1097-1105. PubMed ID: 17350682
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of an arsenic-sensitive monoblastic leukaemia cell line (SigM5).
Walter R; Schoedon G; Bächli E; Betts DR; Hossle JP; Calandra T; Joller-Jemelka HI; Fehr J; Schaffner A
Br J Haematol; 2000 May; 109(2):396-404. PubMed ID: 10848831
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers.
Bergamaschi G; Stella CC; Cattoretti G; Invernizzi R; Maserati E; Nalli G; Pedrazzoli P; Peverali FA; Della Valle G; Ascari E
Br J Haematol; 1991 Jun; 78(2):167-72. PubMed ID: 1648372
[TBL] [Abstract][Full Text] [Related]
19. Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML.
Blatt K; Herrmann H; Hoermann G; Willmann M; Cerny-Reiterer S; Sadovnik I; Herndlhofer S; Streubel B; Rabitsch W; Sperr WR; Mayerhofer M; Rülicke T; Valent P
Clin Cancer Res; 2014 Jul; 20(13):3589-602. PubMed ID: 24799522
[TBL] [Abstract][Full Text] [Related]
20. [Molecular abnormalities and clonality in myelodysplastic syndromes].
Fenaux P; Preudhomme C
Pathol Biol (Paris); 1997 Sep; 45(7):556-60. PubMed ID: 9404479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
